Showing results (881-890 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|March 15, 2008
Paraneoplastic syndromes of the CNSJosep Dalmau, Myrna R Rosenfeld
The Lancet. Neurology|March 15, 2008
Person-centred care of people with severe Alzheimer's disease: current status and ways forwardDavid Edvardsson, Bengt Winblad, P O Sandman
The Lancet. Neurology|May 20, 2008
Intractable epilepsy: management and therapeutic alternativesStephan U Schuele, Hans O Lüders
The Lancet. Neurology|April 18, 2014
Distinct neurological disorders with ATP1A3 mutationsErin L Heinzen, Alexis Arzimanoglou, Allison Brashear, et al.
The Lancet. Neurology|February 1, 2017
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialVincent Meininger, Angela Genge, Leonard H van den Berg, et al.
The Lancet. Neurology|December 11, 2007
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial, P Bentham, R Gray, et al.
The Lancet. Neurology|December 14, 2007
Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trialSteven L Wolf, Carolee J Winstein, J Phillip Miller, et al.
The Lancet. Neurology|December 21, 2007
Mitochondria in the aetiology and pathogenesis of Parkinson's diseaseAnthony H V Schapira
The Lancet. Neurology|November 22, 2016
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyAnette Schrag, Uzma Faisal Siddiqui, Zacharias Anastasiou, et al.
The Lancet. Neurology|October 19, 2016
Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studiesPeter J Kelly, Gregory W Albers, Anastasios Chatzikonstantinou, et al.
Pageof 200